Prior Authorization/Electronic Prior Authorization (ePA)

In a world where innovative therapies are entering the market at an unprecedented pace, stakeholders need quick access to reliable information to help ensure the health care system is working as it should. They need fresh perspectives and data to keep up with how tools and techniques are working to help maintain balance in the managed care ecosystem. Enter AMCP’s recently released 2024 Access, Affordability, and Outcomes (AAO) report, which serves as a useful guide on how managed care pharmacy tools drive impact for patients.

AMCP opposes statutory and regulatory proposals that unduly restrict the ability of pharmacists working within managed care organizations from utilizing tools and services that are essential for the management of a prescription drug benefitFind out about Regulation of the Prescription Drug Benefit.

A retrospective study in JMCP found that pharmacist-adjudicated prior authorization drug requests result in substantial economic benefit, and the prevention of adverse events.

A retrospective study in JMCP found that pharmacist-adjudicated prior authorization drug requests result in substantial economic benefit, and the prevention of adverse events.